CALL - SPRINTER OPEN END - SANOFI Share Price

Certificat

DE000VV0D847

Delayed Deutsche Boerse AG 16:03:33 27/06/2024 BST
1.01 EUR -1.94% Intraday chart for CALL - SPRINTER OPEN END - SANOFI
Current month+9.57%
3 months+5.10%
Date Price Change
27/06/24 1.01 -1.94%
26/06/24 1.03 -7.21%
25/06/24 1.11 +3.74%
24/06/24 1.07 +30.49%
21/06/24 0.82 +2.50%

Delayed Quote Deutsche Boerse AG

Last update June 27, 2024 at 04:03 pm

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Vontobel Vontobel
WKN VV0D84
ISINDE000VV0D847
Date issued 11/08/2022
Strike 79.91
Maturity Unlimited
Parity 10 : 1
Emission price 1.06
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 2.56
Lowest since issue 0.001
Spread 0.01
Spread %0.97%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
90.79 EUR
Average target price
108.2 EUR
Spread / Average Target
+19.17%
Consensus